Connie L. Matsui's most recent trade in Sutro Biopharma Inc was a trade of 50,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 6, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 1,750 | 1,750 | - | - | Stock Option (right to buy) | |
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 29 Nov 2024 | 10,470 | 183,035 (0%) | 0% | 0 | Common Stock | ||
| Sutro Biopharma Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 25 Apr 2024 | 8,804 | 8,804 | - | - | Option to Purchase Common Stock | ||
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 25 Apr 2024 | 6,501 | 193,505 (0%) | 0% | 0 | Common Stock | ||
| Artelo Biosciences Inc | Connie L. Matsui | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 10,634 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 10,634 | 10,634 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 1,767 | 1,767 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 1,767 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 1,083 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 1,083 | 1,083 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 667 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 667 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2024 | 667 | 0 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 667 | 667 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 667 | 667 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2024 | 667 | 667 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 1,083 | 1,083 | - | - | Stock Option (right to buy) | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 667 | 667 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 05 May 2023 | 11,371 | 11,371 | - | - | Option to Purchase Common Stock | ||
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 05 May 2023 | 8,065 | 187,004 (0%) | 0% | 0 | Common Stock | ||
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 16 Nov 2022 | 9,250 | 178,939 (0%) | 0% | 0 | Common Stock | ||
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 05 Nov 2021 | 19,452 | 194,531 (0%) | 0% | 40.1 | 780,531 | Common Stock | |
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 05 Nov 2021 | 12,548 | 181,983 (0%) | 0% | 40.8 | 511,582 | Common Stock | |
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 10,000 | 10,000 | - | - | Stock Option (right to buy) | |
| Sutro Biopharma Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 18,500 | 18,500 | - | - | Stock Option (right to buy) | |
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 05 May 2021 | 5,230 | 213,983 | - | 0 | Restricted Stock Units | ||
| Artelo Biosciences Inc | Connie L. Matsui | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2021 | 159,500 | 159,500 | - | - | Stock Option (right to buy) | |
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 11 Sep 2020 | 32,000 | 216,753 (0%) | 0% | 27.1 | 865,792 | Common Stock | |
| Halozyme Therapeutics Inc. | Connie L. Matsui | Director | 11 Sep 2020 | 8,000 | 208,753 (0%) | 0% | 0 | Common Stock |